A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory Lymphoma
Clinical trial NCT02259010 · COMPLETED
Trial details
- NCT number
- NCT02259010
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-22
- Primary completion
- 2015-03-27
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.